{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:51:03Z","timestamp":1790661063144,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pain is a common problem for children, and pain management comprises both pharmacologic and nonpharmacologic measures. For moderate to severe pain, oral opioids have been a popular choice for the last few decades. Codeine has historically been the best-known oral opioid for use in children. However, availability and use of codeine have sharply declined due to safety concerns. A variety of other opioids have been used in place of codeine, but data are limited regarding their efficacy and safety in children. While the same pathways metabolize oral oxycodone as codeine, oxycodone\u2019s pharmacokinetics varies widely. There are also limited data on the safety and efficacy of oral hydromorphone and tramadol use for children. Oral morphine is the opiate alternative to codeine for which there is the most evidence of safety and efficacy in children. Research is needed to investigate both other opioids and non-opioid approaches to guide evidence-based analgesic therapy and treatment for moderate-to-severe pain in children.<\/jats:p>","DOI":"10.1093\/pch\/pxaa133","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T17:34:23Z","timestamp":1615916063000},"page":"120-123","source":"Crossref","is-referenced-by-count":14,"title":["The use of oral opioids to control children\u2019s pain in the post-codeine era"],"prefix":"10.1093","volume":"26","author":[{"given":"Michael J","family":"Rieder","sequence":"first","affiliation":[{"name":"Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee, Ottawa, Ontario"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert \u2019t","family":"Jong","sequence":"additional","affiliation":[{"name":"Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee, Ottawa, Ontario"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"issue":"1","key":"2021031614494306600_CIT0001","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0304-3959(00)00269-4","article-title":"Pain in children and adolescents: A common experience","volume":"87","author":"Perquin","year":"2000","journal-title":"Pain"},{"issue":"3","key":"2021031614494306600_CIT0002","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpain.2007.10.015","article-title":"The severity of chronic pediatric pain: An epidemiological study","volume":"9","author":"Huguet","year":"2008","journal-title":"J Pain"},{"issue":"5","key":"2021031614494306600_CIT0003","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3821\/145.5.cpj222","article-title":"Pain management in children: Part 1 \u2013 Pain assessment tools and a brief review of nonpharmacological and pharmacological treatment options","volume":"145","author":"Wong","year":"2012","journal-title":"Can Pharm J"},{"issue":"5","key":"2021031614494306600_CIT0004","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11916-018-0685-5","article-title":"America\u2019s opioid epidemic: A comprehensive review and look into the rising crisis","volume":"22","author":"Ostling","year":"2018","journal-title":"Curr Pain Headache Rep"},{"issue":"9","key":"2021031614494306600_CIT0005","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/14622416.9.9.1267","article-title":"Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use","volume":"9","author":"Madadi","year":"2008","journal-title":"Pharmacogenomics"},{"key":"2021031614494306600_CIT0006","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.forsciint.2014.03.018","article-title":"Codeine-related deaths: The role of pharmacogenetics and drug interactions","volume":"239","author":"Lam","year":"2014","journal-title":"Forensic Sci Int"},{"issue":"1","key":"2021031614494306600_CIT0007","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/archdischild-2016-311613","article-title":"Fifteen-minute consultation: Pain relief for children made simple \u2013 a pragmatic approach to prescribing oral analgesia in the postcodeine era","volume":"103","author":"Mason","year":"2018","journal-title":"Arch Dis Child Pract Ed"},{"key":"2021031614494306600_CIT0008","author":"World Health Organization."},{"issue":"1","key":"2021031614494306600_CIT0009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1573396313666170829115631","article-title":"Analgesia for children in acute pain in the post-codeine era","volume":"14","author":"Poonai","year":"2018","journal-title":"Curr Pediatr Rev"},{"issue":"5","key":"2021031614494306600_CIT0010","doi-asserted-by":"crossref","first-page":"e20170186","DOI":"10.1542\/peds.2017-0186","article-title":"Oral analgesics utilization with musculoskeletal injury (OUCH Trial): An RCT","volume":"140","author":"Le May","year":"2017","journal-title":"Pediatr"},{"key":"2021031614494306600_CIT0011","first-page":"CD012538","article-title":"Opioids for chronic non-cancer pain in children and adolescents","volume":"7","author":"Cooper","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2021031614494306600_CIT0012","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s40262-015-0256-4","article-title":"A compartmental analysis for morphine and its metabolites in young children after a single oral dose","volume":"54","author":"Velez de Mendizabal","year":"2015","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"2021031614494306600_CIT0013","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pan.13020","article-title":"Oral morphine dosing predictions based on single dose in children undergoing surgery","volume":"27","author":"Dawes","year":"2017","journal-title":"Pediatr Anesth"},{"issue":"4","key":"2021031614494306600_CIT0014","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00063110-200112000-00004","article-title":"Comparison of oral and intravenous morphine following acute injury in children","volume":"8","author":"Beale","year":"2001","journal-title":"Eur J Emerg Med"},{"issue":"3","key":"2021031614494306600_CIT0015","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1213\/ANE.0000000000001081","article-title":"An analysis of 34,218 pediatric outpatient controlled substance prescriptions","volume":"122","author":"George","year":"2016","journal-title":"Anesth Analg"},{"issue":"12","key":"2021031614494306600_CIT0016","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1553-2712.2008.00266.x","article-title":"Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department","volume":"15","author":"Miner","year":"2008","journal-title":"Acad Emerg Med"},{"issue":"4","key":"2021031614494306600_CIT0017","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/bcp.13164","article-title":"Maturation of oxycodone pharmacokinetics in neonates and infants: Oxycodone and its metabolites in plasma and urine","volume":"83","author":"Kokki","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"2021031614494306600_CIT0018","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2217\/pgs-2016-0183","article-title":"CYP2D6 pharmacogenetic and oxycodone pharmacokinetic association study in pediatric surgical patients","volume":"18","author":"Balyan","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"1","key":"2021031614494306600_CIT0019","first-page":"CD003447","article-title":"Hydromorphone for acute and chronic pain","author":"Quigley","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"2021031614494306600_CIT0020","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"2021031614494306600_CIT0021","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.aco.0000192802.33291.6f","article-title":"Recent developments in the pharmacological management of pain in children","volume":"19","author":"Anderson","year":"2006","journal-title":"Curr Opin Anaesthesiol"},{"issue":"3","key":"2021031614494306600_CIT0022","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/cpdd.169","article-title":"Single- and multiple-dose pharmacokinetic studies of tramadol immediate-release tablets in children and adolescents","volume":"4","author":"Vandenbossche","year":"2015","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"1","key":"2021031614494306600_CIT0023","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0091270002042001002","article-title":"Concordance between tramadol and dextromethorphan parent\/metabolite ratios: The influence of CYP2D6 and non-CYP2D6 pathways on biotransformation","volume":"42","author":"Abdel-Rahman","year":"2002","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"2021031614494306600_CIT0024","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/0310057X1604400613","article-title":"Accuracy of dispersing tramadol capsules for oral administration in young children","volume":"44","author":"Kluger","year":"2016","journal-title":"Anaesth Intensive Care"},{"issue":"2","key":"2021031614494306600_CIT0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00228-017-2367-3","article-title":"Medication errors with tramadol drops in children","volume":"74","author":"Moulis","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"issue":"18","key":"2021031614494306600_CIT0026","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1503\/cmaj.140907","article-title":"Oral administration of morphine versus ibuprofen to manage postfracture pain in children: A randomized trial","volume":"186","author":"Poonai","year":"2014","journal-title":"CMAJ"},{"issue":"40","key":"2021031614494306600_CIT0027","doi-asserted-by":"crossref","first-page":"E1252","DOI":"10.1503\/cmaj.170017","article-title":"Oral morphine versus ibuprofen administered at home for postoperative orthopedic pain in children: A randomized controlled trial","volume":"189","author":"Poonai","year":"2017","journal-title":"CMAJ"}],"container-title":["Paediatrics &amp; Child Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/pch\/article-pdf\/26\/2\/120\/36618154\/pxaa133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/pch\/article-pdf\/26\/2\/120\/36618154\/pxaa133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T17:34:45Z","timestamp":1615916085000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pch\/article\/26\/2\/120\/6174062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,3,16]]},"published-print":{"date-parts":[[2021,3,16]]}},"URL":"https:\/\/doi.org\/10.1093\/pch\/pxaa133","relation":{},"ISSN":["1205-7088","1918-1485"],"issn-type":[{"value":"1205-7088","type":"print"},{"value":"1918-1485","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2021,3,16]]}}}